The impact of acquired immunodeficiency in a patientwith b-cell chronic lymphocytic leukemia on the course ofcoronavirus disease (Covid-19): a case report

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder that affects the bone marrow, lymph nodes, and spleen, and is associated with certain complications. One of the complications of CLL is acquired immunodeficiency, leading to a predisposition for prolonged respiratory viral and bacterial infections. This publication presents a clinical case of a prolonged and severe course of COVID-19 in a patient with CLL, who was successfully treated with immunoglobulin replacement therapy.

Authors

Publication Details

Journal
Wiadomości Lekarskie
Published
2024-12-23
DOI
https://doi.org/10.36740/wlek/197124
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of acquired immunodeficiency in a patientwith b-cell chronic lymphocytic leukemia on the course ofcoronavirus disease (Covid-19): a case report

L. K. Benkovska, O. M. Kostiukevych, Oleksandr V. Naumenko, Mariia A Trypilka
Wiadomości Lekarskie
Chronic Lymphocytic Leukemia Research
article

The impact of acquired immunodeficiency in a patientwith b-cell chronic lymphocytic leukemia on the course ofcoronavirus disease (Covid-19): a case report

L. K. Benkovska, O. M. Kostiukevych, Oleksandr V. Naumenko, Mariia A Trypilka
article en

Abstract

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder that affects the bone marrow, lymph nodes, and spleen, and is associated with certain complications. One of the complications of CLL is acquired immunodeficiency, leading to a predisposition for prolonged respiratory viral and bacterial infections. This publication presents a clinical case of a prolonged and severe course of COVID-19 in a patient with CLL, who was successfully treated with immunoglobulin replacement therapy.

Wiadomości LekarskieVol. 77(11)
Good health and well-being
Openalex Percentile: Top 55%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.